Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma

Immunotherapy is gradually emerging in the field of tumor treatment. However, because of the complexity of the tumor microenvironment (TME), some patients cannot benefit from immunotherapy. Therefore, we comprehensively analyzed the TME and gene mutations of ccRCC to identify a comprehensive index t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ze, Chen, Junxiu, Tao, Yiran, Wang, Qiong, Peng, Shirong, Yu, Shunli, Zeng, Jianwen, Li, Kaiwen, Xie, Zhongqiu, Huang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558467/
https://www.ncbi.nlm.nih.gov/pubmed/34733850
http://dx.doi.org/10.3389/fcell.2021.747985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558467/
https://www.ncbi.nlm.nih.gov/pubmed/34733850
http://dx.doi.org/10.3389/fcell.2021.747985

Ejemplares similares